SCHEMBL23039476

SCHEMBL23039476

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2ccc(-c3nc(-c4ccc(-n5c6ccccc6c6cc(-c7ccccc7)ccc65)cc4)nc(-n4c5ccccc5c5cnccc54)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAOA P21397 4/20 0.38
MAOB P27338 4/20 0.38
ACHE P22303 1/20 0.38
NPY5R Q15761 1/20 0.37
MEN1 O00255 1/20 0.37
HSP90AA1 P07900 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
RAC2 P15153 1/20 0.35
RAC3 P60763 1/20 0.35
CDC42 P60953 1/20 0.35
RAC1 P63000 1/20 0.35
PTGER4 P35408 1/20 0.35
NR3C1 P04150 1/20 0.34
PIK3CD O00329 2/20 0.34
PIK3CA P42336 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21430708 0.98 MAPK10 (0.38) MAPK10KDM4EATML3MBTL1MAOA
SCHEMBL17349356 0.97 ATM (0.42) MAPK10KDM4EATML3MBTL1MAOA
SCHEMBL18958714 0.93 ATM (0.39) MAPK10KDM4EATML3MBTL1MAOA
SCHEMBL18958433 0.93 ATM (0.39) MAPK10KDM4EATML3MBTL1MAOA
SCHEMBL21430849 0.92 MAOA (0.40) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL15945628 0.91 CDK4 (0.38) MAPK10KDM4EATML3MBTL1MAOA
SCHEMBL19269960 0.91 ATM (0.41) MAPK10KDM4EATML3MBTL1MAOA
SCHEMBL17228147 0.91 MAPT (0.45) KDM4EATML3MBTL1NPY5RMEN1
SCHEMBL21481265 0.91 KDM4E (0.46) MAPK10KDM4EATML3MBTL1MAOA
SCHEMBL10059670 0.91 ATM (0.46) KDM4EATML3MBTL1NPY5RMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210066613-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2021-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210066613-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, CYBA, NDUFV3 MAPK10 4821/4885KDM4E 4617/4885ATM 2079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.